Global ingredients company Tate & Lyle says the Australian Patent Office has upheld its allulose syrup patent application claims covering the manufacturing process and use of the syrup.
Tate & Lyle said several organisations challenged the patent claims and it will respond to appeals that have been filed.
“For many years Tate & Lyle has invested significantly in research, development, sustainable manufacturing, applications, technical service, regulatory approvals and securing intellectual property rights relating to allulose solutions. This investment in research and innovation resulted in Tate & Lyle being the first company to commercialise a stabilised allulose syrup and be granted multiple allulose patents in markets around the world,” the company said.
Tate & Lyle senior vice president of Global Platforms, Sweeteners and Fibres, Abigail Storms, said, “Securing, protecting and defending our intellectual property is critical to maintaining our innovation leadership.”
Allulose is a versatile low-calorie sweetener that has myriad applications by providing bulking and sweetness.
The company said it was committed to broad access and availability to its Dolcia Prima LS Allulose Syrup by providing innovation, commercialisation, collaboration and licensing opportunities to other companies in the market.
